Search Within

GME, Medicine

  1. "Master of Science in Clinical and Translational Cancer Research "
Formats
  1. Meeting Abstract (59)
  2. Journal Article (36)
  3. Research Letter (5)
  4. Correspondence (2)
  5. Review (2)
  6. Editorial (1)
Groups
  1. CTCR Scholars (105)
  2. Department of Medicine (105)
  3. Graduate Medical Education (105)
  4. MSK Grad Students (105)
  5. Master of Science in Clinical and Translational Cancer Research (105)
  6. Survivorship Research (84)

More Groups

People
  1. Miguel-Angel Perales (52)
  2. Parastoo Dahi (48)
  3. Michael Scordo (47)
  4. Gunjan Shah (45)
  5. Richard Lin (42)
  6. Maria Palomba (41)

More People

Years
  1. 2025 (9)
  2. 2024 (26)
  3. 2023 (37)
  4. 2022 (22)
  5. 2021 (7)
  6. 2018 (2)

More Years

Publications
  1. Blood (29)
  2. Journal of Clinical Oncology (18)
  3. Transplantation and Cellular Therapy (7)
  4. Blood Advances (4)
  5. Bone Marrow Transplantation (4)
  6. Clinical Cancer Research (3)

More Publications

Publishers
  1. American Society of Hematology (33)
  2. American Society of Clinical Oncology (19)
  3. Elsevier Inc. (11)
  4. Nature Publishing Group (10)
  5. Oxford University Press (6)
  6. American Association for Cancer Research (4)

More Publishers

Results (105)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • A novel approach to quantify heterogeneity of intrahepatic cholangiocarcinoma: The hidden-genome classifier
    Journal Article

    Song, Y.; Boerner, T.; Drill, E.; Shin, P.; Kumar, S.; Sigel, C.; Cercek, A.; Kemeny, N.; Abou-Alfa, G.; Iacobuzio-Donahue, C.; more...
    Clinical Cancer Research (2024)

    Fulltext@MSK | Save
  • Morbidity and mortality in patients with stage IV pancreatic adenocarcinoma and acute cholangitis: Outcomes and risk prognostication
    Journal Article

    Singh, I.; Chou, J. F.; Capanu, M.; Park, J.; Yu, K. H.; Varghese, A. M.; Park, W.; Zervoudakis, A.; Keane, F.; Rolston, V. S.; more...
    Pancreatology (2024)

    Fulltext@MSK | Save
  • BEAM versus pharmacokinetics-directed BuCyVP16 conditioning for patients with peripheral T-cell lymphoma undergoing high-dose therapy with autologous hematopoietic cell transplantation
    Research Letter

    Stuver, R.; Mian, A.; Brown, S.; Devlin, S.; Caimi, P. F.; Chinapen, S.; Dahi, P.; Dean, R.; Epstein-Peterson, Z. D.; Hill, B.; more...
    American Journal of Hematology (2024)

    Fulltext@MSK | Save
  • Conventional and novel [(18)F]FDG PET/CT features as predictors of CAR-T cell therapy outcome in large B-cell lymphoma
    Journal Article

    Leithner, D.; Flynn, J. R.; Devlin, S. M.; Mauguen, A.; Fei, T.; Zeng, S.; Zheng, J.; Imber, B. S.; Hubbeling, H.; Mayerhoefer, M. E.; more...
    Journal of Hematology & Oncology (2024)

    Fulltext@MSK | Save
  • Reduced-intensity compared to nonmyeloablative conditioning in patients with non-Hodgkin lymphoma undergoing allogeneic hematopoietic stem cell transplantation
    Journal Article

    Nath, K.; Peterson, K.; Brown, S.; Devlin, S.; Rodriguez, N.; Barker, J.; Giralt, S.; Gyurkocza, B.; Jakubowski, A.; Papadopoulos, E.; more...
    Transplantation and Cellular Therapy (2024)

    Fulltext@MSK | Save
  • Clinical Factors but not somatic mutations predict for survival in patients with myelofibrosis undergoing allogeneic hematopoietic cell transplant: Analysis of the North American myelofibrosis transplant outcome (NAMTO) study
    Meeting Abstract

    Ajufo, H.; Derkach, A.; Rampal, R. K.; Famulare, C.; Nemirovsky, D.; Chervin, J.; Ho, V.; Gupta, V.; Viswabandya, A.; Deeg, H. J.; more...
    Blood (2023)

    Fulltext@MSK | Save
  • Comparison of bendamustine versus fludarabine/cyclophosphamide lymphodepletion in adult patients receiving CD19 CAR-T cell therapy
    Meeting Abstract

    Landego, I.; Nemirovsky, D.; Devlin, S. M.; Wills, B.; Parascondola, A.; Saldia, A.; Dahi, P. B.; Tomas, A. A.; Ip, A.; Suh, H. C.; more...
    Blood (2023)

    Fulltext@MSK | Save
  • Patterns and safety of glucocorticosteroids use following CD19 CAR-T cell therapy for B-cell lymphoma
    Meeting Abstract

    Luttwak, E.; Flynn, J. R.; Devlin, S. M.; Cassanello, G.; Corona, M.; Dahi, P. B.; Luna De Abia, A.; Fein, J.; Giralt, S. A.; Landego, I.; more...
    Blood (2023)

    Fulltext@MSK | Save
  • The impact of cardiovascular vulnerabilities in non Hodgkin lymphoma patients treated with chimeric antigen receptor T cell therapy
    Meeting Abstract

    Landego, I.; Flynn, J. R.; Goldman, A.; Devlin, S. M.; Luttwak, E.; Luna De Abia, A.; Corona, M.; Kedmi, M.; Sdayoor, I.; Fried, S.; more...
    Blood (2023)

    Fulltext@MSK | Save
  • First fever between lymphodepletion and day 30 after CAR-T cell therapy: Patterns, origins, and implications in lymphoma patients
    Meeting Abstract

    Melica, G.; Luna, A.; Fei, T.; Corona, M.; Dahi, P. B.; Fein, J.; Giralt, S. A.; Raj, S.; Landego, I.; Lin, R. J.; more...
    Blood (2023)

    Fulltext@MSK | Save